203 related articles for article (PubMed ID: 31027422)
1. Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies.
Hardan AY; Hendren RL; Aman MG; Robb A; Melmed RD; Andersen KA; Luchini R; Rahman R; Ali S; Jia XD; Mallick M; Lateiner JE; Palmer RH; Graham SM
Autism; 2019 Nov; 23(8):2096-2111. PubMed ID: 31027422
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension.
Aman MG; Findling RL; Hardan AY; Hendren RL; Melmed RD; Kehinde-Nelson O; Hsu HA; Trugman JM; Palmer RH; Graham SM; Gage AT; Perhach JL; Katz E
J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):403-412. PubMed ID: 26978327
[TBL] [Abstract][Full Text] [Related]
3. Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial.
Häge A; Banaschewski T; Buitelaar JK; Dijkhuizen RM; Franke B; Lythgoe DJ; Mechler K; Williams SC; Dittmann RW;
Trials; 2016 Mar; 17(1):141. PubMed ID: 26983548
[TBL] [Abstract][Full Text] [Related]
4. A Prospective Open-Label Trial of Memantine Hydrochloride for the Treatment of Social Deficits in Intellectually Capable Adults With Autism Spectrum Disorder.
Joshi G; Wozniak J; Faraone SV; Fried R; Chan J; Furtak S; Grimsley E; Conroy K; Kilcullen JR; Woodworth KY; Biederman J
J Clin Psychopharmacol; 2016 Jun; 36(3):262-71. PubMed ID: 27043118
[TBL] [Abstract][Full Text] [Related]
5. Neurocognitive Outcomes from Memantine: A Pilot, Double-Blind, Placebo-Controlled Trial in Children with Autism Spectrum Disorder.
Soorya LV; Fogg L; Ocampo E; Printen M; Youngkin S; Halpern D; Kolevzon A; Lee S; Grodberg D; Anagnostou E
J Child Adolesc Psychopharmacol; 2021 Sep; 31(7):475-484. PubMed ID: 34543081
[No Abstract] [Full Text] [Related]
6. Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial.
Daniels N; Moerkerke M; Steyaert J; Bamps A; Debbaut E; Prinsen J; Tang T; Van der Donck S; Boets B; Alaerts K
Mol Autism; 2023 Apr; 14(1):16. PubMed ID: 37081454
[TBL] [Abstract][Full Text] [Related]
7. Memantine for dementia.
Areosa SA; Sherriff F
Cochrane Database Syst Rev; 2003; (1):CD003154. PubMed ID: 12535459
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.
Peyro Saint Paul L; Creveuil C; Heinzlef O; De Seze J; Vermersch P; Castelnovo G; Cabre P; Debouverie M; Brochet B; Dupuy B; Lebiez P; Sartori É; Clavelou P; Brassat D; Lebrun-Frenay C; Daplaud D; Pelletier J; Coman I; Hautecoeur P; Tourbah A; Defer G
J Neurol Sci; 2016 Apr; 363():69-76. PubMed ID: 27000224
[TBL] [Abstract][Full Text] [Related]
9. Memantine for Prophylactic Treatment of Migraine Without Aura: A Randomized Double-Blind Placebo-Controlled Study.
Noruzzadeh R; Modabbernia A; Aghamollaii V; Ghaffarpour M; Harirchian MH; Salahi S; Nikbakht N; Noruzi N; Tafakhori A
Headache; 2016 Jan; 56(1):95-103. PubMed ID: 26638119
[TBL] [Abstract][Full Text] [Related]
10. Does memantine improve memory in subjects with focal-onset epilepsy and memory dysfunction? A randomized, double-blind, placebo-controlled trial.
Leeman-Markowski BA; Meador KJ; Moo LR; Cole AJ; Hoch DB; Garcia E; Schachter SC
Epilepsy Behav; 2018 Nov; 88():315-324. PubMed ID: 30449328
[TBL] [Abstract][Full Text] [Related]
11. A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia.
Lieberman JA; Papadakis K; Csernansky J; Litman R; Volavka J; Jia XD; Gage A;
Neuropsychopharmacology; 2009 Apr; 34(5):1322-9. PubMed ID: 19005465
[TBL] [Abstract][Full Text] [Related]
12. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
[TBL] [Abstract][Full Text] [Related]
13. Memantine for dementia.
Areosa SA; Sherriff F
Cochrane Database Syst Rev; 2003; (3):CD003154. PubMed ID: 12917950
[TBL] [Abstract][Full Text] [Related]
14. Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.
Feusner JD; Kerwin L; Saxena S; Bystritsky A
Psychopharmacol Bull; 2009; 42(1):81-93. PubMed ID: 19204653
[TBL] [Abstract][Full Text] [Related]
15. Randomized placebo-controlled crossover trial of memantine in children with epileptic encephalopathy.
Schiller K; Berrahmoune S; Dassi C; Corriveau I; Ayash TA; Osterman B; Poulin C; Shevell MI; Simard-Tremblay E; Sébire G; Myers KA
Brain; 2023 Mar; 146(3):873-879. PubMed ID: 36256600
[TBL] [Abstract][Full Text] [Related]
16. Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial.
Anagnostou E; Aman MG; Handen BL; Sanders KB; Shui A; Hollway JA; Brian J; Arnold LE; Capano L; Hellings JA; Butter E; Mankad D; Tumuluru R; Kettel J; Newsom CR; Hadjiyannakis S; Peleg N; Odrobina D; McAuliffe-Bellin S; Zakroysky P; Marler S; Wagner A; Wong T; Macklin EA; Veenstra-VanderWeele J
JAMA Psychiatry; 2016 Sep; 73(9):928-37. PubMed ID: 27556593
[TBL] [Abstract][Full Text] [Related]
17. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.
Guastella AJ; Gray KM; Rinehart NJ; Alvares GA; Tonge BJ; Hickie IB; Keating CM; Cacciotti-Saija C; Einfeld SL
J Child Psychol Psychiatry; 2015 Apr; 56(4):444-52. PubMed ID: 25087908
[TBL] [Abstract][Full Text] [Related]
18. l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
Hajizadeh-Zaker R; Ghajar A; Mesgarpour B; Afarideh M; Mohammadi MR; Akhondzadeh S
J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):74-81. PubMed ID: 29027815
[TBL] [Abstract][Full Text] [Related]
19. A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease.
Reisberg B; Doody R; Stöffler A; Schmitt F; Ferris S; Möbius HJ
Arch Neurol; 2006 Jan; 63(1):49-54. PubMed ID: 16401736
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of adjunctive gabapentin and memantine in obsessive compulsive disorder: Double-blind, randomized, placebo-controlled trial.
Farnia V; Gharehbaghi H; Alikhani M; Almasi A; Golshani S; Tatari F; Davarinejad O; Salemi S; Sadeghi Bahmani D; Holsboer-Trachsler E; Brand S
J Psychiatr Res; 2018 Sep; 104():137-143. PubMed ID: 30044966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]